Review of the experience and evidence of Pygeum africanum in urological practice

Abstract Context Pygeum africanum is still being employed in urology practice for the treatment of lower urinary tract symptoms (LUTS) secondary to benign prostate hyperplasia (BPH). Evidence acquisition A non-exhaustive review has been carried out about Pygeum africanum, its mechanisms of action "in vitro" as well as "in vivo", clinical trials and routine clinical practice. Evidence synthesis The conclusions of the review and the reflections of the authors on the use of Pygeum africanum are described. Conclusions Although with an evidence level IV (based on expert opinion) the use of Pygeum africanum seems to be an option in the urological therapeutic arsenal.